Nordicus Partners Corporation (NORD)
OTCMKTS · Delayed Price · Currency is USD
4.000
-0.100 (-2.44%)
Aug 21, 2026, 9:51 AM EST
Nordicus Partners Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
78.69M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | - | - | - |
| Mar 31, 2025 | 5.00K | 2.50K | 100.00% |
| Mar 31, 2024 | 2.50K | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Karbon-X | 62.41M |
| Entrepreneur Universe Bright Group | 5.06M |
| Meridian Holdings | 1.46M |
| Global AI | 184.28K |
| Balance Labs | 46.00K |
Nordicus Partners News
- 2 months ago - Nordicus Partners Corporation Corporate Update - GlobeNewsWire
- 10 months ago - NoviThera has initiated the first efficacy animal studies - GlobeNewsWire
- 10 months ago - Orocidin's QR-01 Shows Positive Results in Treating Periodontitis in the treatment of experimental periodontitis in Wistar rats. - GlobeNewsWire
- 10 months ago - Orocidin develops novel cGMP manufacturing process in collaboration with Syngene - GlobeNewsWire
- 11 months ago - Nordicus Partners Corporation Announces The Formation Of A New Company, NoviThera ApS - GlobeNewsWire
- 1 year ago - Nordicus Partners Corporation Applies to Uplist to the Nasdaq Capital Market - GlobeNewsWire
- 1 year ago - Nordicus Partners Corporation Appoints Three New Members to Its Board of Directors - GlobeNewsWire
- 1 year ago - Bio-Convert Receives Positive Feedback from The Danish Medicine Agency (DKMA) on its Lead Drug Candidate, QR-02 for Oral Leukoplakia - GlobeNewsWire